-New automatic calculation of the insulin infusion doses that would be applied subcutaneously to a person with diabetes, to discharge him/her from the continuous decision making on their disease control and to induce normoglycemia, thus reducing the health complications derived from poor glycemic control.
-Integration of a glucose predictor algorithm to anticipate the insulin administration
-The insulin dose is conditioned by security and correction systems to avoid hypoglycemia and hyperglycemia events.
-A dose quantifier module adapts the calculated insulin doses to the electromechanical infusion device.
-Implementation in a microprocessor-based system with memory or commercial devices (smartphones, tablets, personal computers).
Competitive advantages: Innovative insulin dose calculation, versatile device that can be used in many other fields of medicine, precise drug delivery to improve a physiological dysfunction. It can be also used in the veterinary and industrial sectors.
To be determined during further development
Patient need addressed: Diabetes, Type 1
Spanish patent application P201830247 (March 3, 2018), International patent, PCT, to be applied
Licensing or Assignment
INVENTOR / TEAM
Agustin Rodriguez, Ma. Elena Hernando, Enrique Gomez, Gema Garcia, Carmen Perez